Harmony of operations of some vitamins in controlling the 2019-nCoV virus based on scientific reports -

[1] R. H. Britten, The incidence of epidemic influenza, 1918-19. Public. Health. Rep., 47 (1932) 304-339.‏
[2] Y. S. Malik, S. Sircar, S. Bhat, K. Sharun, K. Dhama, M. Dadar, W. Chaicumpa, Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Vet. Q., 40 (2020) 68-76.‏
[3] M. A. Alamri, M. T. Qamar, S. F. Alqahtani, Pharmacoinformatics and molecular dynamic simulation studies reveal potential inhibitors of SARS-CoV-2 main protease 3CLpro. Preprints (2020) DOI: 10.20944/preprints202002.0308.v1.
[4] K. Bagherzadeh, K. Daneshvarnejad, M. Abbasinazari, In silico Repositioning for Dual Inhibitor Discovery of SARS-CoV-2 (COVID-19) 3C-like Protease and Papain-like Peptidase. Preprints (2020) DOI: 10.20944/preprints202004.0084.v1
[5] V. Yethindra, Role of GS-5734 (Remdesivir) in inhibiting SARS-CoV and MERS-CoV: The expected role of GS-5734 (Remdesivir) in COVID-19 (2019-nCoV)-VYTR hypothesis. Int. J. Pharm. Sci. Res., 11 (2020) 1-6.‏
[6] L. Dong, S. Hu, J. Gao, Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug. Discov. Ther., 14 (2020) 58-60. ‏
[7] a) S. A. Siadati, M. Afzali, M. Sayyadi, Could silver nano-particles control the 2019-nCoV virus?; An urgent glance to the past. Chem. Rev. Lett., 3 (2020) 9-11.
b) O.. Zachar, Formulations for COVID-19 Early Stage Treatment via Silver Nanoparticles Inhalation Delivery at Home and Hospital. ScienceOpen Preprints., (2020) ‏DOI: 10.14293/S2199-1006.1.SOR-.PPHBJEO.v1;
c) M. Patel, Antimicrobial Paper Embedded with Nanoparticles as Spread-Breaker for Corona Virus. Virus., 3 (2020) 001-012.‏
d) M. Patel, Nanoparticle-based antimicrobial paper as spread-breaker for corona virus. Paper. Technol. Int., 62 (2020) 62, 20-25.‏
[8] A. Casadevall, L. A. Pirofski, The convalescent sera option for containing COVID-19. 130 (2020)1545-1548.‏
[9] N. Narayanan, D. T. Nair, Vitamin B12 May Inhibit RNA-Dependent-RNA Polymerase Activity of nsp12 from the COVID-19. Virus. Preprints., (2020) DOI: 10.20944/preprints202003.0347.v1.
[10] [10] R. Jayawardena, P. Sooriyaarachchi, M. Chourdakis, C. Jeewandara, P. Ranasinghe, Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes. Metab. Syndr., 14 (2020) 367-382.
[11] S. Roy, A. Awasthi, Vitamin A and the Immune System. In Nutrition and Immunity, Cham., 55 (2019) 53-73.
[12] C. Stephensen, Z. Moldoveanu, N. N. Gangopadhyay, Vitamin A deficiency diminishes the salivary immunoglobulin A response and enhances the serum immunoglobulin G response to influenza A virus infection in BALB/c. mice. J. Nutr., 126 (1996) 94-102.
[13] Z. Y. Peng, Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia: a Prospective Randomized Clinical Trial.
https://clinicaltrials.gov/ct2/show/NCT04264533, phase 2 of
clinical trial (2020).
[14] R. Gupta, A. Ghosh, A. K. Singh, A. Misra, Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabete. Metab. Syndr., 14 (2020) 211-212.
[15] A. Erol, High-dose Intravenous Vitamin C Treatment for COVID-19–A Medical Discussion. BMJ. Open., 10 (2020) DOI: 10.1136/bmjopen-2020-039519.
[16] World Health Organization. WHO R&D Blueprint: informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection, Geneva, Switzerland, 24 January 2020 (No. WHO/HEO/R&D Blueprint (‎‎nCoV)‎‎/2020.1). World Health Organization.
[17] L. S. Wang, Y. R. Wang, D. W. Ye, Q. Q. Liu, A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. Int. J. Antimicrob. Agents., 55 (2020) 105948. [19] [19] L. Zhang, Y. Liu, Potential interventions for novel coronavirus in China: a systemic review. J. Med. Virol., 92 (2020) 479-490.
[18] M. Hoffmann, H. Kleine-Weber, N. Krüger, M. A. Mueller, C. Drosten, S. Pöhlmann, The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. (2020) DOI:10.1101/2020.01.31.929042.
[19] J. Xu, J. Yang, J. Chen, Q. Luo, Q. Zhang, H. Zhang, Vitamin D alleviates lipopolysaccharide‑induced acute lung injury via regulation of the renin‑angiotensin system. Res. Mol. Med., 16 (2017) 7432-7438.‏
[20] W. B. Grant, H. Lahore, S. L. McDonnell, C. A. Baggerly, C. B. French, J. L. Aliano, H. P. Bhattoa, Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients., 12 (2020) 988.‏
[21] Ilie PC, Stefanescu S, Smith L. The role of Vitamin D in the prevention of Coronavirus Disease 2019 infection and mortality. (2020) DOI:10.21203/rs.3.rs-21211/v1.
[22] M. Braiman, Latitude Dependence of the COVID-19 Mortality Rate—A Possible Relationship to Vitamin D Deficiency?.Available at SSRN 3561958.‏ (2020) DOI: 10.2139/ssrn.3561958.
[23] M. Alipio, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-2019). Available at SSRN 3571484.‏ (2020) DOI:10.2139/ssrn.3571484 .
[24] H. Hemila, Vitamin C intake and susceptibility to pneumonia. Pediatr. Infect. Dis. J., 16 (1997) 836-837.
[25] D. M. McCartney, D. G. Byrne, Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19. Ir. J. Med. Sci., 113 (2020) 58-58.‏
[26] M. Heinonen, V. Piironen, The tocopherol, tocotrienol, and vitamin E content of the average Finnish diet. Int. J. Vit. Nutr. Res., 61 (1991)27-32.
[27] J. Z. Wang, R. Y. Zhang, J. Bai, An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int. J. Cardiol., (2020) Doi: 10.1016/j.ijcard.2020.04.009.
[28] N. Erol, L. Saglam, Y. S. Saglam, H. S. Erol, S. Altun, M. S. Aktas, The protection potential of antioxidant vitamins against acute respiratory distress syndrome: a rat trial. Inflammation., 42 (2019)1585–1594.
[29] P. K. Law, Emergent Serum Therapy and Antibody Medicine to Counteract Sudden Attacks of COVID-19 and Other Pathogenic Epidemics, Open. J. Regen. Med., 9 (2020) 1-7.
[30] A. Fischer, G. Rimbach, Gene Regulatory Activity of Vitamin E. Vit. E. Human. Health., (2019) 81-98.